nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Epirubicin—testicular cancer	0.349	0.45	CbGbCtD
Silodosin—ADRA1B—vas deferens—testicular cancer	0.0964	0.776	CbGeAlD
Silodosin—ABCB1—Dactinomycin—testicular cancer	0.0825	0.106	CbGbCtD
Silodosin—CYP3A4—Ifosfamide—testicular cancer	0.0584	0.0753	CbGbCtD
Silodosin—ABCB1—Vinblastine—testicular cancer	0.0517	0.0666	CbGbCtD
Silodosin—ABCB1—Cisplatin—testicular cancer	0.0474	0.0611	CbGbCtD
Silodosin—ABCB1—Etoposide—testicular cancer	0.0465	0.06	CbGbCtD
Silodosin—ABCB1—Doxorubicin—testicular cancer	0.0317	0.0409	CbGbCtD
Silodosin—CYP3A4—Vinblastine—testicular cancer	0.031	0.0399	CbGbCtD
Silodosin—ABCB1—Methotrexate—testicular cancer	0.0308	0.0397	CbGbCtD
Silodosin—CYP3A4—Etoposide—testicular cancer	0.0279	0.036	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—testicular cancer	0.019	0.0245	CbGbCtD
Silodosin—ABCB4—testis—testicular cancer	0.00914	0.0736	CbGeAlD
Silodosin—ABCB4—lymph node—testicular cancer	0.00662	0.0533	CbGeAlD
Silodosin—Swollen tongue—Etoposide—testicular cancer	0.00477	0.0475	CcSEcCtD
Silodosin—UGT2B7—testis—testicular cancer	0.00468	0.0377	CbGeAlD
Silodosin—Swelling face—Ifosfamide—testicular cancer	0.00373	0.0371	CcSEcCtD
Silodosin—Rhinorrhoea—Cisplatin—testicular cancer	0.00189	0.0188	CcSEcCtD
Silodosin—ABCB1—embryo—testicular cancer	0.00184	0.0148	CbGeAlD
Silodosin—ABCB1—seminal vesicle—testicular cancer	0.00173	0.0139	CbGeAlD
Silodosin—Hepatic function abnormal—Ifosfamide—testicular cancer	0.00147	0.0147	CcSEcCtD
Silodosin—Jaundice—Chlorambucil—testicular cancer	0.00146	0.0146	CcSEcCtD
Silodosin—Liver function test abnormal—Dactinomycin—testicular cancer	0.0013	0.0129	CcSEcCtD
Silodosin—ABCB1—gonad—testicular cancer	0.00125	0.0101	CbGeAlD
Silodosin—Nasal congestion—Cisplatin—testicular cancer	0.00122	0.0121	CcSEcCtD
Silodosin—Breast disorder—Ifosfamide—testicular cancer	0.00116	0.0116	CcSEcCtD
Silodosin—ABCB1—female gonad—testicular cancer	0.00102	0.00819	CbGeAlD
Silodosin—Orthostatic hypotension—Cisplatin—testicular cancer	0.00101	0.0101	CcSEcCtD
Silodosin—Breast disorder—Cisplatin—testicular cancer	0.001	0.00999	CcSEcCtD
Silodosin—Nasopharyngitis—Cisplatin—testicular cancer	0.000993	0.00989	CcSEcCtD
Silodosin—Hepatobiliary disease—Ifosfamide—testicular cancer	0.000939	0.00935	CcSEcCtD
Silodosin—ABCB1—testis—testicular cancer	0.000902	0.00726	CbGeAlD
Silodosin—Cardiac disorder—Ifosfamide—testicular cancer	0.000827	0.00824	CcSEcCtD
Silodosin—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000826	0.00823	CcSEcCtD
Silodosin—Hepatobiliary disease—Cisplatin—testicular cancer	0.000809	0.00806	CcSEcCtD
Silodosin—Angiopathy—Ifosfamide—testicular cancer	0.000808	0.00805	CcSEcCtD
Silodosin—Immune system disorder—Ifosfamide—testicular cancer	0.000805	0.00802	CcSEcCtD
Silodosin—Mediastinal disorder—Ifosfamide—testicular cancer	0.000803	0.008	CcSEcCtD
Silodosin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000783	0.00779	CcSEcCtD
Silodosin—Mental disorder—Ifosfamide—testicular cancer	0.000781	0.00777	CcSEcCtD
Silodosin—Jaundice—Etoposide—testicular cancer	0.000764	0.00761	CcSEcCtD
Silodosin—Urticaria—Chlorambucil—testicular cancer	0.00076	0.00757	CcSEcCtD
Silodosin—Abdominal pain—Chlorambucil—testicular cancer	0.000757	0.00754	CcSEcCtD
Silodosin—Hepatobiliary disease—Etoposide—testicular cancer	0.000741	0.00738	CcSEcCtD
Silodosin—Gastrointestinal pain—Vinblastine—testicular cancer	0.000717	0.00714	CcSEcCtD
Silodosin—Cardiac disorder—Cisplatin—testicular cancer	0.000713	0.0071	CcSEcCtD
Silodosin—Immune system disorder—Cisplatin—testicular cancer	0.000694	0.00691	CcSEcCtD
Silodosin—Abdominal pain—Vinblastine—testicular cancer	0.000693	0.00691	CcSEcCtD
Silodosin—Mediastinal disorder—Cisplatin—testicular cancer	0.000692	0.0069	CcSEcCtD
Silodosin—Hypotension—Bleomycin—testicular cancer	0.000692	0.00689	CcSEcCtD
Silodosin—Asthenia—Chlorambucil—testicular cancer	0.000687	0.00684	CcSEcCtD
Silodosin—Palpitations—Ifosfamide—testicular cancer	0.000685	0.00683	CcSEcCtD
Silodosin—Pruritus—Chlorambucil—testicular cancer	0.000677	0.00674	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000656	0.00653	CcSEcCtD
Silodosin—Diarrhoea—Chlorambucil—testicular cancer	0.000655	0.00652	CcSEcCtD
Silodosin—ABCB1—lymph node—testicular cancer	0.000654	0.00527	CbGeAlD
Silodosin—Cardiac disorder—Etoposide—testicular cancer	0.000653	0.0065	CcSEcCtD
Silodosin—Hepatic function abnormal—Epirubicin—testicular cancer	0.000652	0.0065	CcSEcCtD
Silodosin—Angiopathy—Etoposide—testicular cancer	0.000638	0.00636	CcSEcCtD
Silodosin—Vascular purpura—Epirubicin—testicular cancer	0.000637	0.00635	CcSEcCtD
Silodosin—Immune system disorder—Etoposide—testicular cancer	0.000636	0.00633	CcSEcCtD
Silodosin—Mediastinal disorder—Etoposide—testicular cancer	0.000634	0.00632	CcSEcCtD
Silodosin—Asthenia—Vinblastine—testicular cancer	0.000629	0.00627	CcSEcCtD
Silodosin—Nervous system disorder—Ifosfamide—testicular cancer	0.000621	0.00618	CcSEcCtD
Silodosin—Skin disorder—Ifosfamide—testicular cancer	0.000615	0.00612	CcSEcCtD
Silodosin—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000604	0.00601	CcSEcCtD
Silodosin—Diarrhoea—Vinblastine—testicular cancer	0.0006	0.00598	CcSEcCtD
Silodosin—Purpura—Epirubicin—testicular cancer	0.000592	0.00589	CcSEcCtD
Silodosin—Hypotension—Ifosfamide—testicular cancer	0.000591	0.00589	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—testicular cancer	0.00059	0.00587	CcSEcCtD
Silodosin—Urticaria—Bleomycin—testicular cancer	0.000588	0.00586	CcSEcCtD
Silodosin—Dizziness—Vinblastine—testicular cancer	0.00058	0.00578	CcSEcCtD
Silodosin—Nausea—Chlorambucil—testicular cancer	0.000568	0.00566	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000565	0.00563	CcSEcCtD
Silodosin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000565	0.00563	CcSEcCtD
Silodosin—Liver function test abnormal—Methotrexate—testicular cancer	0.000563	0.0056	CcSEcCtD
Silodosin—Breast disorder—Methotrexate—testicular cancer	0.000551	0.00548	CcSEcCtD
Silodosin—Headache—Vinblastine—testicular cancer	0.000549	0.00547	CcSEcCtD
Silodosin—Purpura—Doxorubicin—testicular cancer	0.000547	0.00545	CcSEcCtD
Silodosin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000546	0.00544	CcSEcCtD
Silodosin—Abdominal pain—Dactinomycin—testicular cancer	0.000546	0.00544	CcSEcCtD
Silodosin—Loss of consciousness—Etoposide—testicular cancer	0.000538	0.00536	CcSEcCtD
Silodosin—Nervous system disorder—Cisplatin—testicular cancer	0.000535	0.00533	CcSEcCtD
Silodosin—Tachycardia—Cisplatin—testicular cancer	0.000533	0.0053	CcSEcCtD
Silodosin—Asthenia—Bleomycin—testicular cancer	0.000531	0.00529	CcSEcCtD
Silodosin—Skin disorder—Cisplatin—testicular cancer	0.00053	0.00528	CcSEcCtD
Silodosin—Liver function test abnormal—Epirubicin—testicular cancer	0.000526	0.00524	CcSEcCtD
Silodosin—Pruritus—Bleomycin—testicular cancer	0.000524	0.00522	CcSEcCtD
Silodosin—Nausea—Vinblastine—testicular cancer	0.000521	0.00519	CcSEcCtD
Silodosin—Orthostatic hypotension—Epirubicin—testicular cancer	0.000521	0.00519	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000518	0.00516	CcSEcCtD
Silodosin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000518	0.00516	CcSEcCtD
Silodosin—Breast disorder—Epirubicin—testicular cancer	0.000515	0.00513	CcSEcCtD
Silodosin—Hypotension—Cisplatin—testicular cancer	0.00051	0.00508	CcSEcCtD
Silodosin—Nasopharyngitis—Epirubicin—testicular cancer	0.00051	0.00508	CcSEcCtD
Silodosin—Urticaria—Ifosfamide—testicular cancer	0.000503	0.00501	CcSEcCtD
Silodosin—Abdominal pain—Ifosfamide—testicular cancer	0.0005	0.00498	CcSEcCtD
Silodosin—Asthenia—Dactinomycin—testicular cancer	0.000496	0.00494	CcSEcCtD
Silodosin—Tachycardia—Etoposide—testicular cancer	0.000488	0.00486	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—testicular cancer	0.000487	0.00485	CcSEcCtD
Silodosin—Skin disorder—Etoposide—testicular cancer	0.000486	0.00484	CcSEcCtD
Silodosin—Erectile dysfunction—Methotrexate—testicular cancer	0.000485	0.00483	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000482	0.0048	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—testicular cancer	0.000477	0.00475	CcSEcCtD
Silodosin—Diarrhoea—Dactinomycin—testicular cancer	0.000473	0.00471	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000472	0.0047	CcSEcCtD
Silodosin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000471	0.00469	CcSEcCtD
Silodosin—Hypotension—Etoposide—testicular cancer	0.000467	0.00465	CcSEcCtD
Silodosin—Rash—Bleomycin—testicular cancer	0.000467	0.00465	CcSEcCtD
Silodosin—Dermatitis—Bleomycin—testicular cancer	0.000467	0.00465	CcSEcCtD
Silodosin—Asthenia—Ifosfamide—testicular cancer	0.000454	0.00452	CcSEcCtD
Silodosin—Pruritus—Ifosfamide—testicular cancer	0.000448	0.00446	CcSEcCtD
Silodosin—Hepatobiliary disease—Methotrexate—testicular cancer	0.000444	0.00442	CcSEcCtD
Silodosin—Nausea—Bleomycin—testicular cancer	0.00044	0.00438	CcSEcCtD
Silodosin—Rash—Dactinomycin—testicular cancer	0.000436	0.00434	CcSEcCtD
Silodosin—Diarrhoea—Ifosfamide—testicular cancer	0.000433	0.00431	CcSEcCtD
Silodosin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000432	0.0043	CcSEcCtD
Silodosin—Jaundice—Epirubicin—testicular cancer	0.000428	0.00427	CcSEcCtD
Silodosin—Dizziness—Ifosfamide—testicular cancer	0.000419	0.00417	CcSEcCtD
Silodosin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000416	0.00414	CcSEcCtD
Silodosin—Sinusitis—Epirubicin—testicular cancer	0.000412	0.00411	CcSEcCtD
Silodosin—Nausea—Dactinomycin—testicular cancer	0.00041	0.00409	CcSEcCtD
Silodosin—Gastrointestinal pain—Etoposide—testicular cancer	0.000409	0.00407	CcSEcCtD
Silodosin—Rash—Ifosfamide—testicular cancer	0.000399	0.00398	CcSEcCtD
Silodosin—Dermatitis—Ifosfamide—testicular cancer	0.000399	0.00397	CcSEcCtD
Silodosin—Urticaria—Etoposide—testicular cancer	0.000397	0.00396	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—testicular cancer	0.000396	0.00395	CcSEcCtD
Silodosin—Abdominal pain—Etoposide—testicular cancer	0.000395	0.00394	CcSEcCtD
Silodosin—Asthenia—Cisplatin—testicular cancer	0.000392	0.0039	CcSEcCtD
Silodosin—Cardiac disorder—Methotrexate—testicular cancer	0.000391	0.0039	CcSEcCtD
Silodosin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000385	0.00383	CcSEcCtD
Silodosin—Angiopathy—Methotrexate—testicular cancer	0.000382	0.00381	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—testicular cancer	0.000381	0.0038	CcSEcCtD
Silodosin—Immune system disorder—Methotrexate—testicular cancer	0.000381	0.00379	CcSEcCtD
Silodosin—Mediastinal disorder—Methotrexate—testicular cancer	0.00038	0.00378	CcSEcCtD
Silodosin—Nausea—Ifosfamide—testicular cancer	0.000376	0.00375	CcSEcCtD
Silodosin—Diarrhoea—Cisplatin—testicular cancer	0.000373	0.00372	CcSEcCtD
Silodosin—Mental disorder—Methotrexate—testicular cancer	0.000369	0.00368	CcSEcCtD
Silodosin—Cardiac disorder—Epirubicin—testicular cancer	0.000366	0.00365	CcSEcCtD
Silodosin—Asthenia—Etoposide—testicular cancer	0.000359	0.00357	CcSEcCtD
Silodosin—Angiopathy—Epirubicin—testicular cancer	0.000358	0.00356	CcSEcCtD
Silodosin—Immune system disorder—Epirubicin—testicular cancer	0.000356	0.00355	CcSEcCtD
Silodosin—Mediastinal disorder—Epirubicin—testicular cancer	0.000356	0.00354	CcSEcCtD
Silodosin—Pruritus—Etoposide—testicular cancer	0.000354	0.00352	CcSEcCtD
Silodosin—Mental disorder—Epirubicin—testicular cancer	0.000346	0.00344	CcSEcCtD
Silodosin—Rash—Cisplatin—testicular cancer	0.000344	0.00343	CcSEcCtD
Silodosin—Dermatitis—Cisplatin—testicular cancer	0.000344	0.00342	CcSEcCtD
Silodosin—Diarrhoea—Etoposide—testicular cancer	0.000342	0.00341	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—testicular cancer	0.000339	0.00337	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—testicular cancer	0.000331	0.0033	CcSEcCtD
Silodosin—Dizziness—Etoposide—testicular cancer	0.000331	0.00329	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—testicular cancer	0.00033	0.00328	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000329	0.00328	CcSEcCtD
Silodosin—Nausea—Cisplatin—testicular cancer	0.000324	0.00323	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—testicular cancer	0.00032	0.00318	CcSEcCtD
Silodosin—Rash—Etoposide—testicular cancer	0.000315	0.00314	CcSEcCtD
Silodosin—Dermatitis—Etoposide—testicular cancer	0.000315	0.00314	CcSEcCtD
Silodosin—Headache—Etoposide—testicular cancer	0.000313	0.00312	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00031	0.00309	CcSEcCtD
Silodosin—Syncope—Epirubicin—testicular cancer	0.000308	0.00307	CcSEcCtD
Silodosin—Palpitations—Epirubicin—testicular cancer	0.000303	0.00302	CcSEcCtD
Silodosin—Loss of consciousness—Epirubicin—testicular cancer	0.000302	0.00301	CcSEcCtD
Silodosin—Nausea—Etoposide—testicular cancer	0.000297	0.00296	CcSEcCtD
Silodosin—Nervous system disorder—Methotrexate—testicular cancer	0.000294	0.00293	CcSEcCtD
Silodosin—Skin disorder—Methotrexate—testicular cancer	0.000291	0.0029	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00029	0.00289	CcSEcCtD
Silodosin—Dry mouth—Epirubicin—testicular cancer	0.000286	0.00285	CcSEcCtD
Silodosin—Syncope—Doxorubicin—testicular cancer	0.000285	0.00284	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—testicular cancer	0.000281	0.0028	CcSEcCtD
Silodosin—Hypotension—Methotrexate—testicular cancer	0.00028	0.00279	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—testicular cancer	0.000279	0.00278	CcSEcCtD
Silodosin—Shock—Epirubicin—testicular cancer	0.000276	0.00275	CcSEcCtD
Silodosin—Nervous system disorder—Epirubicin—testicular cancer	0.000275	0.00274	CcSEcCtD
Silodosin—Tachycardia—Epirubicin—testicular cancer	0.000274	0.00272	CcSEcCtD
Silodosin—Skin disorder—Epirubicin—testicular cancer	0.000272	0.00271	CcSEcCtD
Silodosin—Insomnia—Methotrexate—testicular cancer	0.000271	0.0027	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000269	0.00268	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—testicular cancer	0.000265	0.00263	CcSEcCtD
Silodosin—Hypotension—Epirubicin—testicular cancer	0.000262	0.00261	CcSEcCtD
Silodosin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000259	0.00258	CcSEcCtD
Silodosin—Shock—Doxorubicin—testicular cancer	0.000255	0.00254	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—testicular cancer	0.000254	0.00253	CcSEcCtD
Silodosin—Insomnia—Epirubicin—testicular cancer	0.000253	0.00252	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—testicular cancer	0.000253	0.00252	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—testicular cancer	0.000252	0.00251	CcSEcCtD
Silodosin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000245	0.00244	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—testicular cancer	0.000242	0.00241	CcSEcCtD
Silodosin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000242	0.00241	CcSEcCtD
Silodosin—Urticaria—Methotrexate—testicular cancer	0.000238	0.00237	CcSEcCtD
Silodosin—Abdominal pain—Methotrexate—testicular cancer	0.000237	0.00236	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—testicular cancer	0.000235	0.00234	CcSEcCtD
Silodosin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000229	0.00228	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000224	0.00223	CcSEcCtD
Silodosin—Urticaria—Epirubicin—testicular cancer	0.000223	0.00222	CcSEcCtD
Silodosin—Abdominal pain—Epirubicin—testicular cancer	0.000222	0.00221	CcSEcCtD
Silodosin—Asthenia—Methotrexate—testicular cancer	0.000215	0.00214	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000212	0.00211	CcSEcCtD
Silodosin—Pruritus—Methotrexate—testicular cancer	0.000212	0.00211	CcSEcCtD
Silodosin—Urticaria—Doxorubicin—testicular cancer	0.000206	0.00205	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—testicular cancer	0.000205	0.00204	CcSEcCtD
Silodosin—Diarrhoea—Methotrexate—testicular cancer	0.000205	0.00204	CcSEcCtD
Silodosin—Asthenia—Epirubicin—testicular cancer	0.000201	0.002	CcSEcCtD
Silodosin—Pruritus—Epirubicin—testicular cancer	0.000198	0.00197	CcSEcCtD
Silodosin—Dizziness—Methotrexate—testicular cancer	0.000198	0.00197	CcSEcCtD
Silodosin—Diarrhoea—Epirubicin—testicular cancer	0.000192	0.00191	CcSEcCtD
Silodosin—Rash—Methotrexate—testicular cancer	0.000189	0.00188	CcSEcCtD
Silodosin—Dermatitis—Methotrexate—testicular cancer	0.000189	0.00188	CcSEcCtD
Silodosin—Headache—Methotrexate—testicular cancer	0.000188	0.00187	CcSEcCtD
Silodosin—Asthenia—Doxorubicin—testicular cancer	0.000186	0.00185	CcSEcCtD
Silodosin—Dizziness—Epirubicin—testicular cancer	0.000185	0.00185	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—testicular cancer	0.000183	0.00183	CcSEcCtD
Silodosin—Nausea—Methotrexate—testicular cancer	0.000178	0.00177	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—testicular cancer	0.000177	0.00177	CcSEcCtD
Silodosin—Rash—Epirubicin—testicular cancer	0.000177	0.00176	CcSEcCtD
Silodosin—Dermatitis—Epirubicin—testicular cancer	0.000177	0.00176	CcSEcCtD
Silodosin—Headache—Epirubicin—testicular cancer	0.000176	0.00175	CcSEcCtD
Silodosin—Dizziness—Doxorubicin—testicular cancer	0.000171	0.00171	CcSEcCtD
Silodosin—Nausea—Epirubicin—testicular cancer	0.000166	0.00166	CcSEcCtD
Silodosin—Rash—Doxorubicin—testicular cancer	0.000163	0.00163	CcSEcCtD
Silodosin—Dermatitis—Doxorubicin—testicular cancer	0.000163	0.00163	CcSEcCtD
Silodosin—Headache—Doxorubicin—testicular cancer	0.000162	0.00162	CcSEcCtD
Silodosin—Nausea—Doxorubicin—testicular cancer	0.000154	0.00153	CcSEcCtD
